7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Verde ME et al. Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. 2015 Acta Odontol Latinoam pmid:27095621
Li B et al. Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. 2015 Genet. Mol. Res. pmid:26782591
Zang L et al. The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. 2015 Sci Rep pmid:26671549
Liu W et al. Polymorphisms in three genes are associated with hemorrhagic stroke. 2015 Brain Behav pmid:26664786
Pesce Viglietti AI et al. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. 2015 Infect. Immun. pmid:26459511
Nemeth ZK et al. Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. 2015 Sci Rep pmid:26459001
Zhang HL and Jin X Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. 2015 Genet. Mol. Res. pmid:26400332
Ren H et al. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. 2015 Mol Med Rep pmid:26398911
Board-Davies E et al. Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. 2015 Stem Cells Transl Med pmid:26378260
Kato G et al. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. 2015 Arthritis Res. Ther. pmid:26373710
Li CW et al. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. 2015 Genet. Mol. Res. pmid:26345854
Pan X et al. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. 2015 PLoS ONE pmid:26334877
Wang B et al. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. 2015 Sci Rep pmid:26329493
Ostrowska Z et al. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2015 Endokrynol Pol pmid:26323468
Kulcsar-Jakab E et al. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. 2015 BMC Musculoskelet Disord pmid:26311162
Miao X et al. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. 2015 J Orthop Surg Res pmid:26148858
Fernández-González FJ et al. Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. 2015 Dental Press J Orthod pmid:26560822
Bartosińska J et al. The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. 2015 Mediators Inflamm. pmid:26146462
Ye XH et al. Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. 2015 Genet. Mol. Res. pmid:26125863
Yu SG et al. Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. 2015 Int J Clin Exp Pathol pmid:26097549
Schmitz F et al. Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. 2015 Cell Metab. pmid:26094892
Kondegowda NG et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. 2015 Cell Metab. pmid:26094891
Telejko B et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. 2015 Ann Agric Environ Med pmid:26094529
Ketlogetswe KS et al. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. 2015 J. Acquir. Immune Defic. Syndr. pmid:26090754
Burton LJ et al. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. 2015 Carcinogenesis pmid:26069256
Collins FL et al. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. 2015 J Immunol Res pmid:26065008
Zavala-Cerna MG et al. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. 2015 J Immunol Res pmid:26065000
Davenport C et al. The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes. 2015 J Diabetes Res pmid:26064990
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
Kim KR et al. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. 2015 PLoS ONE pmid:25859665
Wu C et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. 2015 Genes Dev. pmid:25846796
Åšwierkot J et al. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25837853
Hassan SH et al. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. 2015 Dis. Markers pmid:25814780
Folestad A et al. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. 2015 Acta Orthop pmid:25811776
Sutton KM et al. The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. 2015 Dev. Comp. Immunol. pmid:25796577
Zheng Y et al. Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. 2015 J. Dent. Res. pmid:25762594
Tsuruda T Osteoprotegerin: osteo-vascular connection. 2015 J. Atheroscler. Thromb. pmid:25740050
Shah M et al. Local origins impart conserved bone type-related differences in human osteoblast behaviour. 2015 Eur Cell Mater pmid:25738584
Alwood JS et al. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue. 2015 J. Interferon Cytokine Res. pmid:25734366
Majerczyk M et al. [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. 2015 Postepy Hig Med Dosw (Online) pmid:27259222
Fu Y et al. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. 2015 J. Vet. Sci. pmid:25549213
Lin TH et al. NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. 2015 Tissue Eng Part A pmid:25518013
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Rao M et al. Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. 2015 Exp. Hematol. pmid:25461255
Estanislau IM et al. Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. 2015 Br J Clin Pharmacol pmid:25444240
Meijome TE et al. GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. 2015 J. Cell. Physiol. pmid:25205203
Solberg LB et al. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. 2015 Histochem. Cell Biol. pmid:25201349
Potocka-Bakłażec M et al. Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis. 2015 Eur Arch Otorhinolaryngol pmid:24676726

Table of Content